Published by Josh White on 6th June 2025
(Sharecast News) - Avacta Group reported a reduced pre-tax loss of £28.98m from continuing operations in 2024 on Friday, down from £31.13m the year prior, as it accelerated its transformation into a pure-play oncology biotech.
URL: http://www.digitallook.com/dl/news/story/35133313/...